We design, manage and monitor our own clinical trials

ORBiT

We have recently completed a Phase 2 in-clinic trial testing our DynamX-Bx technology for oesophageal and colon cancer screening.  This trial was performed at four independent sites across the UK.

RADiCAL

We are working with Portsmouth NHS Trust on an Innovate UK funded programme to develop our non-invasive DynamX-Cs solution for early-stage screening and detection of lung cancer.